A publisher has set out some clues to a promising ASX listed explorer in the Kalahari....market cap around 500 million, share price about 1.26. Any suggestions?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%